Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2
Yaniv Lustig, Ital Nemet, Limor Kliker, Neta S. Zuckerman, Ruti Yishai, Sharon Alroy‐Preis, Ella Mendelson, Michal Mandelboim
Abstract
Vaccination after SARS-CoV-2 Infection Six patients previously infected with the original SARS-CoV-2 virus received the BNT162b2 vaccine. Before vaccination, they had neutralizing activity against ...
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VaccinationVirologyCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakMedicineNeutralizing antibodyVirusOutbreakInfectious disease (medical specialty)Internal medicineDiseaseSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyBacillus and Francisella bacterial research